Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yesterday, someone who works in a state institution for Drug Addiction told me the drug of choice that they prescribe now is Mallinckrodt's Roxycodone
http://www2.mallinckrodt.com/Brands/Opioid_Products/
http://www.rxlist.com/roxicodone-15-30-mg-drug.htm
https://www.google.com/search?q=roxycodone&ie=utf-8&oe=utf-8
Maybe MNK would make a good partner for Rexista XR.
This is just a guess... but I think an educated guess.
If/when you enter into negotiations the first thing you sign is a non-competing clause... that is... you will not seek nor invite nor partake in any negotiations whatsoever regarding the product/service that you are "in good faith" negotiating about.
My guess is they are negotiating with someone - and have therefore entered a blackout period... and presenting at a conference COULD be viewed as inviting competing offers.
As I said... All a guess on my part.
I know I own 110k shares and I wasn't contacted
I don't think Friday's run up was in any way related to news leak, or buy out rumor, or any of that.
I think it was totally due to someone taking a look at IPCI.... liking what they saw... and wanted perhaps 250K shares, driving it up 25 cents.
Wait till several funds take a look at IPCI.... like what they see... and want perhaps 1 million shares, driving it up $1.00 at a time.
Over and over and over ! ! !
How many days are left before we are in the Clear?
I guess there's a serious investor now!!!
Numbers....thanks for the DD and finding this. actually, it is exactly this reason why the company does not report ongoing communications with the FDA in PR's. what would be the point if the FDA requests additional information? it may not be that anything was wrong, just additional testing now being required. the whole reason they have dialogue with companies is to tell the company what needs added or corrected for approval. the bashers on this company would take any opportunity to say "see they dont know what they are doing" we already are getting it with people saying they will never get past advisory committee with the FDA with Rexista.
also, then you have the issue like Focalin where because of time, new BE requirements were required and the company was then required to meet new BE even though they already had tentative approval. these ANDA's being filed in 2010, who is to say new requirements were not added?
the only thing we can really say is 100% the FDA has been on contact with the company in regards to their ANDA's on probably more than 1 of them and the company does indeed have a good reasonable expectation as to what is coming. which is why its important to actually listen and read when they put on these conferences to what is said and how they say it. when they indicate "we feel confident the FDA is making progress on the applications" that is telling because they already know what the FDA has been telling them.
So IPCI estimated launch date is around August 28, 2017
YES! I was right... just relax and enjoy all the money you will earn in the next 3 years
All Products sold or offered for sale by Mallinckrodt shall be labeled with Mallinckrodt’s name, trademarks and trade dress as per label artwork provided and paid for by Mallinckrodt
Mallinckrodt shall have the right, upon thirty (30) days advance written notice of Mallinckrodt’s intention to terminate the Agreement to Intellipharmaceutics hereunder (and, with respect to any given Product, before it has been approved by the FDA), to terminate this Agreement (i) as to Product One if the FDA has not approved the ANDA for Product One on or before December 31, 2017, DONE (ii) as to Product Two if the FDA has not approved the ANDA for Product Two on or before December 31, 2018, (iii) as to Product Three if the FDA has not approved the ANDA for Product Three on or before December 31, 2018
Actually I hope you're right and IPCI somehow incorporates the January and February Focalin Sales in the 1st quarter reporting... as this would make it more apparent that there is likely no need to raise money in the near future or ever again for that matter.
I think it's imperative now to make it crystal clear that there is no further dilution required to a hostile poison financeeer.
I believe you don't short 1.8 million shares without thinking you can get that quantity stock from the company when they reach out to do a fund raiser... I think it's important right now for IPCI to shout out %$&8 @#+... we've got enough not to ever dilute again!!!
I think securing a partner for Glucophage where they receive ~ $1 million upfront milestone payment... even if it means accepting a smaller % royalty would go a long way to causing a panic in the shorts camp.
ps: More than likely whoever partners Rexista and/or Regabatin will want a stake in IPCI... I'm assuming around 3 million shares... but I don't consider that a negative.
yea I just dont know, it was a strange way to say that.
Quote: Par provides reports, probably monthly - your assumption.
That is correct. I cannot deduce the timing of Par's reporting based on the terminology in the contract.
One need only ask Della Penna
Licensing revenue amounts receivable by the Company under this agreement are calculated and reported to the Company by Par, with such amounts generally based upon net product sales and net profit which include estimates for chargebacks, rebates, product returns, and other adjustments
Par provides reports, probably monthly - your assumption
"as long as Seroquel is on the market, they dont care about the remaining ones"
"Filling the gap" is one of those words of wisdom phrases similar to:
"Deer always walk into the wind"
Since we live in a world where there are predominantly westerly winds... I guess all the deer are now packed tightly on the edge of the Pacific Ocean... all piled on the California shores... dear god... who is going to clean up all those deer droppings in the sand???
For the rest 60K long (very long hopefully)
Don't believe that. It is what they want you to believe. We went down too easily and very fast too. I said before: Company needs to bring out news! FDA did, so now it IPCI's turn! If they fail this week, we all know where we are heading back to.
Wow - $2.57 to $2.74 in seconds... where it took out a block of 18,900 shares in one gulp - and back down again - I think there's a fund accumulating... very carefully accumulating.
Angelo- Look at the dates again, it looks like it took over a year for Troxyca XR to be approved.
Numbers - I hope you understood that I was refuting J_Cali's assertion that Pfizer dropped Remoxy because they had ALO-02... they dropped Remoxy because they failed twice and apparently they believed it would have failed a third time... which it did.
But your timeline introduces an interesting point.
Feb 13, 2015 Pfizer's Troxyca NDA Accepted for Review. So probably filed NDA in December 2014.
Aug 19, 2016 FDA Approves Troxyca ER.
I would say the three names mentioned are three companies you can take off the partner list.
If they were talking to them they certainly wouldn't have mentioned them. He provided the names as examples of big pharmaceutical companies.
Pfizer by the way inherited Remoxy from The buyout of King but gave it up since they already had an opiod product. ???
Yes, interesting action as the move up to $2.80 was met with two asks of 8000+, clearly trying to put lid on the pm trading. Something is up, no doubt about it...
Many many moons ago... I did some research as to what big pharma would be a good fit for IPCI... and I came up with Pfizer mostly to protect it's Lyrica franchise... or Novartis to go head to head with Pfizer pitting Regabatin against Lyrica... in fact I was really hot on Novartis back then when I felt that eventually Regabatin would prove to be the Jewel in the crown rather than Rexista... not that Rexista wouldn't be a jewel in itself.
Would be nice to see Novartis partner up... they do drive a hard bargain... and do demand stock purchase... but you can count on wild success with them at the rudder.
$60 million non-refundable? No chance
I don't usually buy into rumors... but this one feeeels right.
In mentioning potential partners during the presentation, Della Penna said "Novartis, Pfiser, and/or Teva" I have a tendency to believe the one you're most in bed with gets mentioned first... also Novartis is Swiss... and rumor coming from Germany would make more sense than elsewhere... and partnership rumor includes Regabatin which pits Novartis against Pfizer on a $4 Billion drug.
Yeaaa... I'm going to give this one 20% credibility.
Keep in minder that till today mngmnt didn't bode Well when it came to make deals.
If you truly believe what you're saying... why pussy foot around and only sell 10K... why not sell the other 40K... you can then buy the whole 60K back under $2.00???
You would also be doing your part in helping your buddies drive it down... instead of getting a free ride.
I believe there are only 2 doses in all - the 500 and 750
Not sure what to make of your numbers... I know I want to believe IPCI's numbers... and kind of do... simply because diabetes is huge and find it hard to believe that ADHD is a bigger market than diabetes... even if Glucophage has greater competition and therefore lower per pill price.
Maybe someone can help... hint hint... numbers.
Exactly what I was going to suggest to IPCI - the shorts would have to pay that for the borrowed shares.
There were 18 when I counted them a month ago - not likely 40 now - even your list says around 18 if you remove dupes.
Lots of distributors... but... Big, Big market.
$2.7 billion market totally generic... 1% equals $27 million x 40% royalties = $10.8 million per year per 1%
This is big.
They are building it Fabius - Glad you're here!!!
Glucophage is the one I wanted next - many distributors... but a $2.7 billion GENERIC market... just 1% of that is $27 million - give IPCI 40% royalties and that is a pure $10.8 million a year... and they can start anyday... no waiting 180 days.
I'm assuming a $1 million up front payment - as the others got - and that SCREAMS no toxic financing necessary ever again.
I believe it was being brought down purposefully by the pack of #@&%*#&^ with the intent of covering their short with the stock from another toxic financing... now they are twisting in the wind... where are they going to get 2 million shares from???
If anyone believes this I got property on the moon to sell you too.
It seems clear Odidi is keeping more than something under the radar. Why?
I don't see it as a pump and dump at all.
I see it as just the opposite - as a short and accumulate!!! my guess is that out of those 450K traded today, perhaps 75K to 100K actually traded hands... from weak hands to manipulating hands.
I don't think that this methodical day after day suppression of price is because longs are afraid of holding and selling out of fear... but Market Makers and the warrant holders suppressing the price and gathering loose shares shaken from weak hands.
Why... because they know it's a bargain and they want as much as they can get... they have much deeper pockets than we have and are able to do so... and those 1.5 million warrants give them the security they need in case it goes against them.
Snap out of it people - this is a $50 stock in the making - those who appear to be selling are actually accumulating... because they know that
20K shares today makes them a millionaire in 3 to 5 years!!! because you sold to them!!!
Angelo- How naïve are you... Impact sold the news. Enough said.
Do you own IPCI in a margin account???
Yea... I was aware of that post... and now I'm thinking even more-so that he may be at the end of this constant downward pressure.
The margin requirement may be a part of it... compounded by perhaps that he may be selling out to satisfy other money requirements, above and beyond the margin calls.
How far can you drop the stock by selling 600K shares???
Would like to hear from him if he is selling out.
Perhaps this daily decline may not be as nefarious as we've all made out to be.
I believe ImpactTrader stated he had 600K shares.
If... he owns that in a margin account... then he may well be hit on a daily basis with margin calls.
A 10 cent drop in IPCI's price would equate to an additional $60K in margin requirement... thereby necessitating liquidating ~ 30K shares... thereby causing another 10 cent drop in pricing... particularly if there is someone selling back and forth picking up his loose shares as he re-balances on a daily basis.
Just a WAG.